Creative Commons source reading · Neurodegeneration biomarkers and longitudinal studies
Sleep and APOE-ε4 have a synergistic effect on plasma biomarkers and longitudinal cognitive decline in older adults.
Xianfeng Yu; Xia Zhou; Zhengbo He; Beiqi He; Ke Wan; Min Wei; Tengfei Guo; Ying Han
Originally published in CNS neuroscience & therapeutics · 2024-02-01
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
Background Sleep disorders are prevalent among patients with Alzheimer's disease (AD), and the APOE ε4 genotype is a key genetic risk factor for sporadic AD. However, the combined effect of the genotype and sleep disorders on cognitive decline remains uncertain. Methods A total of 972 participants were drawn from the SILCODE cohort, comprising 655 without the ε4 allele (APOE-) and 317 with ε4 allele (APOE+). Data were collected, including neuropsychological assessments, sleep measurements, plasma biomarkers, and PET imaging. A Sleep Composite Index (SCI) was created, categorizing participants into high risk (Sleep+) and low risk (Sleep-). Results Significant predictions of dementia risk associated with plasma p-tau181, neurofilament light chain (NfL), and SCI. Individuals with both Sleep+ and APOE+ had a higher risk of dementia compared to those with Sleep-. The Sleep+/APOE+ group had higher plasma NfL levels than the Sleep-/APOE- group. Similar trends emerged in plasma NfL levels among the Aβ PET-positive subgroup. Plasma NfL levels explained 23% of the relationship between SCI and cognitive impairment.
DISCUSSION
This large‐scale multimodal biomarker study utilized PSQI, RBDSQ, and ESS sleep‐related questionnaires to assess individuals' overall sleep status (represented by SCI) and examined the association of SCI, SCI‐APOE genotype subgroups, plasma biomarker levels related to AD, and longitudinal cognitive changes. We found that APOE ε4 as genetic risk factor could exacerbate effect of sleep disorder on risk conversion to dementia.
CONCLUSION
In conclusion, this study revealed the association between SCI and AD plasma biomarkers, as well as explored whether these associations were modulated by APOE ε4 allele carriage. In this cohort study of cognitively healthy elderly individuals, we found that sleep disruption is linked to future dementia, particularly in APOE ε4 carriers, which was partially explained by the increased plasma NfL concentrations. Additionally, we found that APOE ε4 carriers with sleep disorder had the highest plasma NfL and GFAP compared to the other groups.
Editorial reading guide
- Was the evidence cross-sectional, longitudinal or experimental?
- How did the authors account for age, disease stage and differences among participants?
